GLAXOSMITHKLINE FINANCE PLC
ActiveCompany number 00242686
London, United Kingdom · Incorporated 2 October 1929
79 New Oxford Street, London, WC1A 1DG, United Kingdom
Last updated on 21 September 2026
Financial intermediation not elsewhere classified · SIC 64999
Company history
BEECHAM FOODS LIMITED · 2 October 1929 – 31 December 1980
BEECHAM FINANCE P L C · 31 December 1980 – 3 October 1989
SMITHKLINE BEECHAM FINANCE P.L.C. · 3 October 1989 – 1 October 2001
Company overview
GLAXOSMITHKLINE FINANCE PLC is a public limited company registered in England and Wales since its incorporation on 2 October 1929 and remains active on the register. It has changed its name 3 times, most recently from SMITHKLINE BEECHAM FINANCE P.L.C. on 3 October 1989. Its registered office is at 79 New Oxford Street, London, WC1A 1DG, United Kingdom. Its principal activity is financial intermediation not elsewhere classified (SIC 64999).
It is controlled by Glaxosmithkline Holdings Limited, which holds 75-100% of the shares and voting rights and has the right to appoint and remove directors. The board consists of four British directors: EDINBURGH PHARMACEUTICAL INDUSTRIES LIMITED (appointed 28 February 2001), GLAXO GROUP LIMITED (appointed 28 February 2001), THE WELLCOME FOUNDATION LIMITED (appointed 5 March 2007) and WALKER, Adam (appointed 11 February 2019). WHYTE, Victoria Anne serves as company secretary (appointed 18 January 2002). The company has been served by 16 former officers who have since resigned.
The company has no charges, no insolvency history and has never been liquidated. The company filed its most recent full accounts, covering the period to 31 December 2025, on 14 July 2026. The next accounts are due by 30 June 2027. Its most recent confirmation statement was made up to 29 April 2026. The next is due by 13 May 2027. 217 filings are recorded against the company at Companies House, most recently an accounts filing on 14 July 2026.
Compliance
Financial snapshot
Detailed figures (assets, liabilities, net worth) are available in the full credit report.
Capital table
Updated on 21 September 2026- GLAXOSMITHKLINE HOLDINGS LIMITED (100.0%)
- ESKAYLAB LIMITED (0.0%)
Share classes
| Class | Allocated shares | Currency | Nominal value | Voting | Dividend | Transfer | Anti-dilution |
|---|---|---|---|---|---|---|---|
| ORDINARY | 17,870,000,002 | — | — | ||||
| Total | 17,870,000,002 | ||||||
Shareholders
| Shareholder | Share class | Shares | Shareholding | Votes | Voting |
|---|---|---|---|---|---|
| ESKAYLAB LIMITED | ORDINARY | 0 | 0.00% | 0 | 0.00% |
| GLAXOSMITHKLINE HOLDINGS LIMITED | ORDINARY | 17,870,000,002 | 100.00% | 17,870,000,002 | 100.00% |
| Total | 17,870,000,002 | 100% | 17,870,000,002 | 100% |
Officers
Persons with significant control
Funding
2 funding roundsFiling history
No filings match this type.
Risk at a glance
- Company active
- Accounts up to date
- Confirmation statement up to date
- No insolvency history
- No registered charges
- Credit score
- Recommended limit
- Payment risk
Get the complete credit report
- Detailed financial statements
- Credit score & payment risk
- CCJs, charges & insolvency checks
- Recommended credit limit
Secure checkout · Report delivered instantly
Related companies
Sharing officers with this company